Follow Us!Share This!The Drug Enforcement Administration published the following notice in the Federal Register on September 28: As noted, until now, Epidiolex has been a schedule I controlled substance. By virtue of this order, Epidiolex (and any generic versions of the same formulation that might be approved by the FDA in the future) will be a schedule V controlled substance. Thus, all persons in the distribution chain who handle Epidiolex in the United States (importers, manufacturers, distributors, and practitioners) must…
Read more

Follow Us!Share This!The state of New York has added pain management to its list of eligible conditions for patients seeking to qualify for a recommendation for medical cannabis. According to a press release from the Office of the Governor of New York on Sept. 24, 2018: Governor Andrew M. Cuomo today signed legislation (S8987A/A 11011-B) that adds acute pain management to the list of conditions for which medical marijuana can be recommended as an alternative to opioid use. The bill…
Read more

Follow Us!Share This!The state of Illinois has expanded its medical cannabis program to allow patients access to medical cannabis as an alternative to opioid pain medications. The Chicago Sun-Times reported on August 28, 2018: Gov. Bruce Rauner on Tuesday signed a landmark bill to allow patients access to medical marijuana as an alternative to opioids, but the Republican governor — who’s in a battle for his political future — said he still opposes legalizing pot for recreational uses. The Sun-Times…
Read more

Follow Us!Share This!Congress is continuing to prevent doctors working at VA hospitals from recommending medical cannabis for their patients who are in need. Stars and Stripes reported on September 11, 2018: A measure to allow doctors at the Department of Veterans Affairs to recommend marijuana in states where it’s medically legal failed to make it into the final version of a VA funding bill for the third consecutive year. Lawmakers on Monday released their VA funding agreement for fiscal 2019…
Read more